Hypothesis: Combined inhibition of complement and cd14 as treatment regimen to attenuate the inflammatory response

Advances in Experimental Medicine and Biology

Volumn 632, Issue , 2008, Pages 253-263

  Mollnes, Tom Eirik ^a,b   Christiansen, Dorte ^c   Brekke, Ole Lars ^b   Espevik, Terje ^d  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c NORDLAND HOSPITAL   (Norway)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CD14 ANTIGEN; COMPLEMENT; CYTOKINE; ENDOTOXIN; ERITORAN; LIPOPOLYSACCHARIDE; PROTEIN MD 2; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4;

ANTIGEN BINDING; ANTIGEN RECOGNITION; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; CROSS LINKING; CYTOKINE PRODUCTION; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; HOST; HOST RESISTANCE; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION; BIOLOGICAL MODEL; HUMAN; IMMUNOLOGY; METABOLISM; PILOT STUDY;

ANIMALIA; NEGIBACTERIA;

ANTIGENS, CD14; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; ENDOTOXINS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MODELS, IMMUNOLOGICAL; PILOT PROJECTS; SEPSIS; TOLL-LIKE RECEPTOR 4;

EID: 49549114823     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78952-1_18     Document Type: Review

References (43)

1. Brekke, O.L., Christiansen, D., Fure, H., Fung, M., and Mollnes, T.E. (2007) The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood. J Leukoc Biol 81, 1404-1413
2. Castellheim, A., Lindenskov, P.H., Pharo, A., Fung, M., Saugstad, O.D., and Mollnes, T.E. (2004) Meconium is a potent activator of complement in human serum and in piglets. Pediatr Res 55, 310-318
3. Castellheim, A., Lindenskov, P.H., Pharo, A., Aamodt, G., Saugstad, O.D., and Mollnes, T.E. (2005) Meconium aspiration syndrome induces complement-associated systemic inflammatory response in newborn piglets. Scand J Immunol 61, 217-225
4. Choe, J., Kelker, M.S., and Wilson, I.A. (2005) Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 309, 581-585
5. Chong, A.J., Shimamoto, A., Hampton, C.R., Takayama, H., Spring, D.J., Rothnie, C.L., Yada, M., Pohlman, T.H., and Verrier, E.D. (2004) Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg 128, 170-179
6. Collard, C.D., Vakeva, A., Morrissey, M.A., Agah, A., Rollins, S.A., Reenstra, W.R., Buras, J.A., Meri, S., and Stahl, G.L. (2000) Complement activation after oxidative stress - role of the lectin complement pathway. Am J Pathol 156, 1549-1556
7. Daubeuf, B., Mathison, J., Spiller, S., Hugues, S., Herren, S., Ferlin, W., Kosco-Vilbois, M., Wagner, H., Kirschning, C.J., Ulevitch, R., and Elson, G. (2007) TLR4/MD-2 Monoclonal antibody therapy affords protection in experimental models of septic shock. J Immunol 179, 6107-6114
8. Frey, E.A., Miller, D.S., Jahr, T.G., Sundan, A., Bazil, V., Espevik, T., Finlay, B.B., and Wright, S.D. (1992) Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 176, 1665-1671
9. Gay, N.J. and Gangloff, M. (2007) Structure and function of toll receptors and their ligands. Annu Rev Biochem 76, 141-165
10. Hawlisch, H. and Kohl, J. (2006) Complement and Toll-like receptors: key regulators of adaptive immune responses. Mol Immunol 43, 13-21
11. Husebye, H., Halaas, O., Stenmark, H., Tunheim, G., Sandanger, O., Bogen, B., Brech, A., Latz, E., and Espevik, T. (2006) Endocytic pathways regulate toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J 25, 683-692
12. Johnsen, I.B., Nguyen, T.T., Ringdal, M., Tryggestad, A.M., Bakke, O., Lien, E., Espevik, T., and Anthonsen, M.W. (2006) Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling. EMBO J 25, 3335-3346
13. Kaczorowski, D.J., Nakao, A., Mollen, K.P., Vallabhaneni, R., Sugimoto, R., Kohmoto, J., Tobita, K., Zuckerbraun, B.S., Mccurry, K.R., Murase, N., and Billiar, T.R. (2007) Toll-like receptor 4 mediates the early inflammatory response after cold ischemia/reperfusion. Transplantation 84, 1279-1287
14. Kim, H.M., Park, B.S., Kim, J.I., Kim, S.E., Lee, J., Oh, S.C., Enkhbayar, P., Matsushima, N., Lee, H., Yoo, O.J., and Lee, J.O. (2007a) Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist eritoran. Cell 130, 906-917
15. Kim, S.C., Ghanem, A., Stapel, H., Tiemann, K., Knuefermann, P., Hoeft, A., Meyer, R., Grohe, C., Knowlton, A.A., and Baumgarten, G. (2007b) Toll-like receptor 4 deficiency: smaller infarcts, but no gain in function. BMC Physiol 7, 5
16. Kohl, J. (2006) The role of complement in danger sensing and transmission. Immunol Res 34, 157-176
17. Latz, E., Visintin, A., Lien, E., Fitzgerald, K.A., Monks, B.G., Kurt-Jones, E.A., Golenbock, D.T., and Espevik, T. (2002) Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem 277, 47834-47843
18. Latz, E., Schoenemeyer, A., Visintin, A., Fitzgerald, K.A., Monks, B.G., Knetter, C.F., Lien, E., Nilsen, N.J., Espevik, T., and Golenbock, D.T. (2004) TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 5, 190-198
19. Lien, E., Aukrust, P., Sundan, A., Muller, F., Froland, S.S., and Espevik, T. (1998) Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events. Blood 92, 2084-2092
20. Lindenskov, P.H., Castellheim, A., Aamodt, G., Saugstad, O.D., and Mollnes, T.E. (2004) Complement activation reflects severity of meconium aspiration syndrome in newborn pigs. Pediatr Res 56, 810-817
21. Marchant, A., Tielemans, C., Husson, C., Gastaldello, K., Schurmans, T., De, G.D., Duchow, J., Vanherweghem, L., and Goldman, M. (1996) Cuprophane haemodialysis induces upregulation of LPS receptor (CD14) on monocytes: role of complement activation. Nephrol Dial Transplant 11, 657-662
22. Mollnes, T.E. and Kirschfink, M. (2006) Strategies of therapeutic complement inhibition. Mol Immunol 43, 107-121
23. Mollnes, T.E., Brekke, O.L., Fung, M., Fure, H., Christiansen, D., Bergseth, G., Videm, V., Lappegard, K.T., Kohl, J., and Lambris, J.D. (2002a) Essential role of the C5a receptor in E. coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 100, 1869-1877
24. Mollnes, T.E., Song, W.C., and Lambris, J.D. (2002b) Complement in inflammatory tissue damage and disease. Trends Immunol 23, 61-64
25. Mollnes, T.E., Jokiranta, T.S., Truedsson, L., Nilsson, B., Rodriguez de, C.S., and Kirschfink, M. (2007) Complement analysis in the 21st century. Mol Immunol 44, 3838-3849
26. Ohto, U., Fukase, K., Miyake, K., and Satow, Y. (2007) Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science 316, 1632-1634
27. Riedemann, N.C., Guo, R.F., Hollmann, T.J., Gao, H., Neff, T.A., Reuben, J.S., Speyer, C.L., Sarma, J.V., Wetsel, R.A., Zetoune, F.S., and Ward, P.A. (2003a) Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J 370-372
28. Riedemann, N.C., Neff, T.A., Guo, R.F., Bernacki, K.D., Laudes, I.J., Sarma, J.V., Lambris, J.D., and Ward, P.A. (2003b) Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J Immunol 170, 503-507
29. Salvesen, B., Fung, M., Saugstad, O.D., and Mollnes, T.E. (2008) The role of complement and CD14 in meconium-induced cytokine formation. Pediatrics 121, e496-e505
30. Sendide, K., Reiner, N.E., Lee, J.S., Bourgoin, S., Talal, A., and Hmama, Z. (2005) Crosstalk between CD14 and complement receptor 3 promotes phagocytosis of Mycobacteria: regulation by phosphatidylinositol 3-kinase and cytohesin-1. J Immunol 174, 4210-4219
31. Shimamoto, A., Chong, A.J., Yada, M., Shomura, S., Takayama, H., Fleisig, A.J., Agnew, M.L., Hampton, C.R., Rothnie, C.L., Spring, D.J., Pohlman, T.H., Shimpo, H., and Verrier, E.D. (2006) Inhibition of toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 114, I270-I274
32. Sprong, T., Moller, A.S., Bjerre, A., Wedege, E., Kierulf, P., van der Meer, J.W., Brandtzaeg, P., van Deuren, M., and Mollnes, T.E. (2004) Complement activation and complement-dependent inflammation by Neisseria meningitidis are independent of lipopolysaccharide. Infect Immun 72, 3344-3349
33. Tang, A.H., Brunn, G.J., Cascalho, M., and Platt, J.L. (2007) Pivotal advance: endogenous pathway to SIRS, sepsis, and related conditions. J Leukoc Biol 82, 282-285
34. Uematsu, S. and Akira, S. (2007) Toll-like receptors and type I interferons. J Biol Chem 282, 15319-15323
35. van Bruggen, R., Zweers, D., van, D.A., van Dissel, J.T., Roos, D., Verhoeven, A.J., and Kuijpers, T.W. (2007) Complement receptor 3 and Toll-like receptor 4 act sequentially in uptake and intr cellular killing of unopsonized Salmonella enterica serovar typhimurium by human neutrophils. Infect Immun 75, 2655-2660
36. Walport, M.J. (2001a) Advances in immunology: complement (First of two parts). N Engl J Med 344, 1058-1066
37. Walport, M.J. (2001b) Advances in immunology: complement (Second of two parts). N Engl J Med 344, 1140-1144
38. Ward, P.A. (2004) The dark side of C5A in sepsis. Nat Rev Immunol 4, 133-142
39. Weingarten, R., Sklar, L.A., Mathison, J.C., Omidi, S., Ainsworth, T., Simon, S., Ulevitch, R.J., and Tobias, P.S. (1993) Interactions of lipopolysaccharide with neutrophils in blood via CD14. J Leukoc Biol 53, 518-524
40. Yamada, M., Oritani, K., Kaisho, T., Ishikawa, J., Yoshida, H., Takahashi, I., Kawamoto, S., Ishida, N., Ujiie, H., Masaie, H., Botto, M., Tomiyama, Y., and Matsuzawa, Y. (2004) Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells. Eur J Immunol 34, 221-230
41. Zarewych, D.M., Kindzelskii, A.L., Todd, R.F., III, and Petty, H.R. (1996) LPS induces CD14 association with complement receptor type 3, which is reversed by neutrophil adhesion. J Immunol 156, 430-433
42. Zhang, M. and Carroll, M.C. (2007) Natural IgM-mediated innate autoimmunity: a new target for early intervention of ischemia-reperfusion injury. Expert Opin Biol Ther 7, 1575-1582
43. Zhang, X., Kimura, Y., Fang, C., Zhou, L., Sfyroera, G., Lambris, J.D., Wetsel, R.A., Miwa, T., and Song, W.C. (2007) Regulation of toll-like receptor-mediated inflammatory response by complement in vivo. Blood 110, 228-236